Syncom Formulations
19.11
-0.14(-0.73%)
Market Cap₹1,809.50 Cr
PE Ratio36.34
IndustryHealthcare
Company Performance:
1D-0.73%
1M-12.42%
6M-8.21%
1Y+49.88%
5Y+135.93%
View Company Insightsright
Latest news about Syncom Formulations
Syncom Formulations Reports Impressive Q4 Results with Soaring Profits and Revenue May 20, 2025
Syncom Formulations announced impressive Q4 financial results. Net profit soared 159.26% year-over-year to ₹175.00 crore, up 36.72% quarter-over-quarter. Revenue reached ₹1,500.00 crore, a 104.72% increase from the previous year. The company's strong performance indicates effective business strategies and high market demand for its products.
Syncom Formulations Reports Impressive Q4 Financial Results with Substantial Growth May 19, 2025